Sign In
Buy NVO
$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
Novo Nordisk, Eli Lilly Could Fatten Up on Weight-Loss Treatments
05:51pm, Wednesday, 31'st Aug 2022
Given that less than 3% of the 110 million obese Americans are being treated with drugs, new medications from Novo Nordisk AS ( NVO , Financial) and Eli Lilly and Co. ( LLY , Financial) could fatten t
3 Stocks to Buy Before the Housing Market Crashes
12:45pm, Friday, 26'th Aug 2022
The notion of a looming housing market crash appears to be picking up steam. There are multiple signs the ongoing correction could morph into something worse.
Novo Nordisk: Assessing Hype Towards Obesity Care Following The Q2 Results Drop, Story Is Intact
05:57pm, Tuesday, 23'rd Aug 2022
A true compounder, Novo Nordisk is positioning itself beyond basal insulin amid market and government pressures. Crucial to this strategy is its fledgling Obesity Care unit, buoyed by successes like W
Novo (NVO) Posts Positive Data From Diabetes Study on CagriSema
03:02pm, Tuesday, 23'rd Aug 2022
Novo Nordisk (NVO) completes the phase II study evaluating CagriSema, a combination of semaglutide and cagrilintide for treating type II diabetes.
Novo Nordisk: Looming Danger In An Excellent Business
03:34pm, Monday, 15'th Aug 2022
NVO had excellent results in the past and a promising position to profit even further. Its pipeline should support good revenue and earnings growth in the coming years.
3 Stocks to Buy and Hold Forever
06:11am, Saturday, 13'th Aug 2022
These stocks are keepers.
7 Long-Term Stocks to Buy Before the Bull Market Returns
02:45pm, Sunday, 07'th Aug 2022
The current market conditions aren't conducive for short-term investing. It's notoriously difficult to pick winning stocks with a limited time horizon, and it becomes doubly true in this extremely vol
Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
10:12am, Friday, 05'th Aug 2022 Benzinga
Gainers
ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per sh
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
08:00am, Friday, 05'th Aug 2022 Benzinga
U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session.
ChemoCentryx, Inc. (NASDAQ: CCXI)
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
05:12pm, Thursday, 04'th Aug 2022 Benzinga
Gainers
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.
Onion Global Limited (NYSE: OG) gained 113.9% to $0.8556.
ChemoCentryx,
Novo Nordisk's (NVO) Q2 Earnings Miss, Sales Beat Estimates
04:26pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Novo Nordisk (NVO) missed estimates for earnings in the second quarter of 2022 while revenues beat the same, driven by growth in Diabetes and Obesity Care on higher GLP-1 revenues.
Novo Nordisk (NVO) Q2 2022 Earnings Call Transcript
02:00pm, Thursday, 04'th Aug 2022 The Motley Fool
NVO earnings call for the period ending June 30, 2022.
Alibaba, MercadoLibre And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
11:59am, Thursday, 04'th Aug 2022 Benzinga
Global Blood Therapeutics, Inc. (NASDAQ: GBT) rose 19.3% to $40.47 in pre-market trading following a report suggesting the company is attracting takeover interest. According to a Bloomberg report, cit
Why Is Yellow Trading Higher By 33%: Here Are 48 Stocks Moving Premarket
10:51am, Thursday, 04'th Aug 2022 Benzinga
Gainers
Missfresh Limited (NASDAQ: MF) shares rose 112.9% to $0.2450 in pre-market trading after dropping 7% on Wednesday.
GreenLight Biosciences Holdings (NASDAQ: GRNA) shares rose 100.6% to $6.54 i
Novo Nordisk CEO on treating diabetes and obesity, and challenges facing the industry
09:09am, Thursday, 04'th Aug 2022
Novo Nordisk CEO Lars Jorgensen discusses the company's latest results, developing and supplying the world with medication and devices to treat diabetes, and logistical challenges facing the company a
